GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
WEBGAZYVA ® (obinutuzumab) is a prescription medicine used in combination with chemotherapy, followed by GAZYVA alone in those who responded, to treat stage II bulky, III, or IV follicular lymphoma (FL) in adults who have not had previous FL treatment.
GAZYVA® (obinutuzumab) Dosing Schedule | First-Line CLL
WEBGAZYVA is given for a total of 6 cycles, or rounds of treatment. Each cycle will last 28 days. Treatment occurs only on certain days of each cycle and that is usually followed by several weeks of rest and recovery. This means that most people will complete their GAZYVA treatment in about 6 months.
How GAZYVA® (obinutuzumab) is Thought to Work in First-Line CLL
WEBLearn how GAZYVA® (obinutuzumab) is thought to work as an antibody therapy for patients with previously untreated chronic lymphocytic leukemia. See important safety including Boxed Warnings for more information.
GAZYVA® (obinutuzumab) Side Effects & Safety Info | Untreated FL
WEBGAZYVA can cause side effects that can become serious or life-threatening, including: Hepatitis B Virus (HBV): Hepatitis B can cause liver failure and death. If you have a history of hepatitis B infection, GAZYVA could cause it to return. You should not receive GAZYVA if you have active hepatitis B liver disease.
GAZYVA treatment schedule for first-line follicular lymphoma
WEBGAZYVA ® (obinutuzumab) is a prescription medicine used in combination with chemotherapy, followed by GAZYVA alone in those who responded, to treat stage II bulky, III, or IV follicular lymphoma (FL) in adults who have not had previous FL treatment.
GAZYVA® (obinutuzumab) Clinical Trial Results | First-Line …
WEBGAZYVA ® (obinutuzumab) is a prescription medicine used in combination with chemotherapy, followed by GAZYVA alone in those who responded, to treat stage II bulky, III, or IV follicular lymphoma (FL) in adults who have not had previous FL treatment.
How GAZYVA® (obinutuzumab) is Thought to Work in R/R …
WEBGAZYVA is a type of antibody therapy that targets and attaches to the CD20 proteins found on follicular lymphoma cells as well as some healthy blood cells. Once attached to the CD20 protein, GAZYVA is thought to work in different ways, including: By helping your own immune system destroy the cancer cells By destroying the cancer cells directly
Financial Assistance Options | GAZYVA (obinutuzumab)
WEBLearn about the financial assistance options for people taking GAZYVA (obinutuzumab), including for those who don't have insurance. See full safety for more information. Prescribing Information
GAZYVA® (obinutuzumab) Side Effects & Safety | First-Line …
WEBGAZYVA ® (obinutuzumab) is a prescription medicine used in combination with chemotherapy, followed by GAZYVA alone in those who responded, to treat stage II bulky, III, or IV follicular lymphoma (FL) in adults who have not had previous FL treatment.
Indications and Important Safety Information - gazyva
WEBGAZYVA ® (obinutuzumab) is a prescription medicine used in combination with chemotherapy, followed by GAZYVA alone in those who responded, to treat stage II bulky, III, or IV follicular lymphoma (FL) in adults who have not had previous FL treatment.